Inj meropenem (wg crit care)
Products billed under this code include Meropenem.
Payment limit per 100 MG, by effective quarter, 3Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Meropenem.
Payment limit per 100 MG, by effective quarter, 3Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Meropenem | WG Critical Care, LLC | 44567-0402-06 | 120 | $160.68 |
| Meropenem | Mylan Institutional LLC | 72078-0081-06 | 120 | $160.68 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $1.339 | −$0.069 | 100 MG | Inj meropenem (wg crit care) | v1, posted September 17, 2026 |
| 3Q26 | $1.408 | −$0.068 | 100 MG | Inj meropenem (wg crit care) | v1, posted September 15, 2026 |
| 2Q26 | $1.476 | −$0.096 | 100 MG | Inj meropenem (wg crit care) | v1, posted September 15, 2026 |
| 1Q26 | $1.572 | −$0.048 | 100 MG | Inj meropenem (wg crit care) | v1, posted September 15, 2026 |
| 4Q25 | $1.62 | −$0.004 | 100 MG | Inj meropenem (wg crit care) | v1, posted September 8, 2026 |
| 3Q25 | $1.624 | +$0.02 | 100 MG | Inj meropenem (wg crit care) | v1, posted March 10, 2026 |
| 2Q25 | $1.604 | −$0.05 | 100 MG | Inj meropenem (wg crit care) | v1, posted March 10, 2026 |
| 1Q25 | $1.654 | +$0.037 | 100 MG | Inj meropenem (wg crit care) | v1, posted December 19, 2025 |
| 4Q24 | $1.617 | +$0.016 | 100 MG | Inj meropenem (wg crit care) | v1, posted June 11, 2025 |
| 3Q24 | $1.601 | – | 100 MG | Inj meropenem (wg crit care) | v1, posted June 11, 2025 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.